Fig. 3From: Optimizing palliative chemotherapy for advanced invasive mucinous adenocarcinoma of the lungKaplan-Meier estimates of overall survival (OS) outcomes in the IMA study patients based on targeted therapy (Panel A), and immunotherapy (Panel B)Back to article page